Enzon Pharmaceuticals, Inc. (ENZN)
Market Open
30 Jul, 20:00
OTC PINK OTC PINK Primary $
4. 71
+0.06
+1.2903%
$
31.14M Market Cap
- P/E Ratio
0.48% Div Yield
1,300 Volume
- Eps
$ 4.65
Previous Close Want to track ENZN and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Enzon Pharmaceuticals, Inc. (ENZN) Statistics
Valuation metrics
Market Cap 31.14M
Enterprise value 98.14M
Trailing P/E (ttm) -0.91
Forward P/E -
PEG ratio 0.01
Price/Sales (ttm) 0.18
Price/Book (mrq) 0.36
Enterprise Value/Revenue 0.56
Enterprise Value/EBITDA -50.3
Overview
Shares outstanding -
Float -
Shares short -
% Held by insiders -
% Held by institutions -
Average volume (10 days) 862
Average volume (90 days) 1.56K
Price summary
52-Week low 4
52-Week high 33.8
Beta -
50-Day moving average 4.81
200-Day moving average 5.98
Dividends and splits
Forward annual dividend rate -
Forward annual dividend yield -
Trailing annual dividend rate -
Trailing annual dividend yield -
5-Year annual dividend yield -
Payout ratio -
Dividend Date 15 Oct 2019
Ex-Dividend Date 30 Sep 2019
Last split factor 1:100
Last split Date 25 Mar 2026
Financials
Fiscal year
Fiscal year ends -
Most recent quarter (mrq) -
Profitability
Profit margin -0.08%
Operating margin -0.02%
Operational effectiveness
Return on assets -0.03%
Return on equity -0.12%
Income Statement
Revenue (ttm) -
Revenue per share (ttm) 12.33
Quarterly revenue growth (yoy) -
Gross profit (ttm) -
EBITDA -
Net income to common (ttm) -
Diluted EPS (ttm) -0.95
Quarterly earnings growth (yoy) -
Balance Sheet
Total cash (mrq) -
Total cash per share (mrq) 0.55
Total debt (mrq) -
Total Debt/Equity (mrq) 0.4
Current ratio (mrq) 1.84%
Book value per share (mrq) 13.03
Cash Flow
Cash flow statement -
Levered free cash flow (LFCF) -
